Introduction
Maintenance of genomic integrity within the cell requires co-ordination between cell-cycle regulated DNA replication and DNA repair to avoid mutation and genomic instability. Analysis of proteins that are required for both processes may give insight into the mechanism of co-ordination. For this reason, we have chosen to study proliferating cell nuclear antigen (PCNA).
Proliferating cell nuclear antigen is essential for DNA replication, acting as the processivity factor for DNA polymerases d and e. As a homotrimer, PCNA forms a toroidal structure capable of interacting nonspeci®cally with double stranded DNA by encircling it, and thus forming a sliding clamp which tethers the polymerase to the DNA strand (Krishna et al., 1994;  reviewed by Kuriyan and O'Donnell, 1993) . PCNA is highly conserved and has been identi®ed as an essential gene required for DNA replication in the yeasts Schizosaccharomyces pombe (Waseem et al., 1992) and Saccharomyces cerevisiae (Bauer and Burger, 1990) . In addition to its role in replication, however, PCNA is also required for nucleotide excision repair in cell-free systems (Shivji et al., 1992; Nichols and Sancar, 1992) , and plays a role in one pathway of base excision repair (Matsumoto et al., 1994) . The way in which PCNA activity is regulated to carry out these two separate roles is as yet unclear, though recently discovered interactions of PCNA with p21
Cip1 (Xiong et al., 1992; Waga et al., 1994b; Flores et al., 1994; Warbrick et al., 1995) and Gadd45 (Smith et al., 1994; Hall et al., 1995) may provide some insight into these regulatory phenomena.
Prokaryotic DNA polymerases, such as Escherichia coli DNA polymerase I have a 5' ± 3' exonuclease domain which is required for the completion of lagging strand synthesis. Eukaryotic DNA polymerases do not contain such a domain, the equivalent activity being provided by the Fen1 (Flap endonuclease 1) nuclease. Consistent with its corresponding functional activity, Fen1 shows signi®cant sequence homology with the 5' ± 3' exonuclease domain in DNA polymerase I (Robins et al., 1994) . Fen1 plays an key role in DNA replication: it is essential for SV40 DNA replication in vitro and has been shown to be required, in combination with RNase H, for Okazaki fragment processing (Siegal et al., 1992; Waga et al., 1994a) . A bovine homologue of Fen1 has been detected in highly puri®ed fractions of DNA polymerase e, and is required for complete DNA synthesis on a synthetic DNA substrate in a lagging strand reaction (Siegal et al., 1992; Turchi and Bambara, 1993; Murante et al., 1994) .
Fen1 is a structure-speci®c endonuclease showing high speci®city of binding and activity towards 5'¯ap structures, which comprise double stranded DNA with a displaced 5' single strand (Harrington and Lieber, 1994a) . The activity is independent of¯ap length and is highly speci®c, since other branch structures such as Holliday junctions are not cleaved (Harrington and Leiber, 1995) . In addition, Fen1 possesses 5' ± 3' exonuclease activity speci®c for double stranded DNA Lieber, 1994a, 1995) . The S cerevisiae homologue of Fen1, RAD27 (RTH1, YKL510) shares many characteristics with genes known to be involved in DNA replication (Reagan et al., 1995; Sommers et al., 1995) . rad27 deletion mutants show a slow growth rate, and are temperature sensitive with a terminal phenotype characteristic of a defect in DNA replication (Reagan et al., 1995) . However, these mutants show high sensitivity to the alkylating agent MMS, with only slight sensitivity to g and u.v. irradiation, suggesting that RAD27 may also play a role in base excision repair (Reagan et al., 1995; Sommers et al., 1995) . Mutations in S pombe rad2, which encodes a Fen1 homologue, can be complemented by expression of human Fen1 (rad2 hs ) (Murray et al., 1994) . In contrast to RAD27, S pombe rad2 mutants are sensitive to u.v. irradiation, though epistasis analysis indicates that rad2 may act through an alternative pathway to the conserved excision repair pathway (Murray et al., 1994) .
The Fen1 protein belongs to a superfamily of structure speci®c endonucleases, which share two regions of homology associated with nuclease activity, and which fall into two classes or families based on overall amino acid homology. One family contains Fen1 and its homologues, the other the Xeroderma Pigmentosum complementation group G (XPG) protein in humans, and includes yeast homologues, RAD2 in S cerevisiae and rad13 in S pombe (Scherly et al., 1993; Madura and Prakash, 1986; Carr et al., 1993) . Fen1 is not required for nucleotide excision repair and in vitro studies have shown that the corresponding nuclease activity is supplied by the XPG protein (O'Donovan et al., 1994; Aboussekhra et al., 1995) . XPG cuts 3' of the damaged oligonucleotide, while other nucleotide excision repair proteins (the XPF/ERCC1 complex) cut at the 5' side of the lesion (O'Donovan et al., 1994) .
PCNA has been shown to interact physically with Fen1 and to stimulate both its exonucleolytic activity and its endonucleolytic activity at branched DNA structures (Li et al., 1995; Wu et al., 1996) . We have identi®ed the interaction of Fen1 with human PCNA through a two hybrid screening approach and have extensively characterised the Fen1-PCNA interaction. Mapping of the mutual binding sites of each protein reveals that Fen1 binds to the same region of PCNA as does p21
Cip1 , the cyclin-kinase inhibitor that also blocks PCNA's function in DNA replication (Waga et al., 1994b; Flores et al., 1994; Warbrick et al., 1995) but not repair (Li et al., 1994; Shivji et al., 1994) . The regions of Fen1 and p21
Cip1 that interact with PCNA are shown to be homologous, and p21
Cip1 peptides are found to compete with Fen1 for binding to PCNA, both in ELISA and during DNA replication in vitro. This competition between Fen1 and p21
Cip1 for binding to PCNA may provide clues as to how the cessation of DNA replication is co-ordinated with onset of DNA repair following genomic damage.
Results

Fen1 binds PCNA in a yeast two hybrid screen
We screened for proteins that interact physically with human PCNA using a two hybrid interaction trap system that detects protein-protein interactions by reconstitution of a functional Gal4 transcription activator in the yeast Saccharomyces cerevisiae (Fields and Song, 1989) . A plasmid expressing human PCNA as a fusion protein with the DNA binding domain of Gal4 (Gal4 AS ) was used to screen plasmids expressing fusion constructs of molecules encoded by a human cDNA library with the transcriptional activation domain of Gal4 (Gal4 ACT ) . Two classes of clones were identi®ed in this screen. One class of clones encoded p21
Cip1 , while in the second class, one clone was found to encode full length Fen1 (including a short upstream region) with eight other clones encoding fragments of Fen1 that interacted with PCNA to give signi®cant levels of b-galactosidase activity compared to controls. The minimal Fen1 fragment isolated in our screen (Figure 1 ) encoded the C-terminal 88 amino acids of the protein (full length 380 aa, Murray et al., 1994) , thus localizing a PCNA binding site to these residues. PCNA from Drosophila melanogaster and Schizosaccharomyces pombe also interacted in this system with human Fen1 (data not shown), suggesting strong evolutionary conservation of the interaction site.
Direct interaction between Fen1 and PCNA demonstrated in Far-Western
A Far-Western blotting technique was used to con®rm that the interaction between Fen1 and PCNA is direct, and not an artefact of the two hybrid system (Figure 2 ). Strips of a nitrocellulose blot of recombinant Fen1 protein were exposed to bacterial cell lysate expressing either recombinant PCNA or recombinant Fen1. PCNA and Fen1 were detected with the anti-PCNA antibody 3009 or the novel anti-Fen1 polyclonal antibody 3220, respectively. Fen1 migrates under these conditions to an apparent molecular weight of 48 kDa, while a band of the same size was detected by the anti-PCNA antibody 3009 only after preincubation of the blot with recombinant human PCNA. This was not seen when the blot was incubated with diluent alone, indicating that this represents a direct and speci®c association of PCNA with Fen1. Preincubation of the blot with recombinant Fen1 protein also permitted recognition of the 48 kDa band by antibody 3220, even leading to a slight (Picksley et al., 1994; Warbrick et al., 1995) . To map precisely the residues of Fen1 to which PCNA binds, a series of biotinylated 20 amino acids peptides (with 15 amino acid overlaps) were synthesized. These peptides correspond to the 88 amino acid C terminal minimal region of Fen1 found to interact with PCNA in the two hybrid screen (Figure 1 ). Peptides were bound to streptavidin agarose beads then incubated with human HeLa cell extracts. The beads were precipitated and bound protein analysed on immunoblots probed with monoclonal anti-PCNA antibody PC10 (Waseem and Lane, 1990) . The results in Figure  3 show that PCNA was precipitated from HeLa Cell extract with equal eciency by Fen1 peptides 84, 85 and 86, strongly suggesting that the amino acids TQGRLDDFFK common to these three peptides are important for binding to PCNA. The PCNA-binding peptides of Fen1 were designated Fen1PBPs (PCNAbinding peptides).
Comparison of the amount of PCNA present in the undepleted extract and that precipitated by Fen1 peptides 84, 85 and 86, suggests a high anity interaction between PCNA and the Fen1PBPs. Additionally, PCNA did not interact with any other peptides within these C-terminal 88 amino acids, indicating a speci®c interaction of human PCNA with residues 336 ± 345 of human Fen1.
Evolutionary conservation of the Fen1-PCNA interaction
Human Fen1 interacted with both Drosophila and S pombe PCNA in two hybrid analysis screen (data not shown). Murray et al. have shown that the S pombe Fen1 homologue Rad2 interacts with PCNA using both two hybrid analysis and immunoprecipitation of tagged proteins from S pombe cells (Pers. comm.). To determine if the Fen1-PCNA interaction acts through an evolutionarily conserved mechanism, we investigated the binding of the homologues of Fen1, Rad2 from S pombe (Murray et al., 1994) and RAD27 from S cerevisiae (Jacquier et al., 1992) to human PCNA. Biotinylated 20 amino acid peptides corresponding to the PCNA binding site determined for human Fen1 were synthesized for these yeast homologues ( Figure  4b ). These peptides were immobilised on streptavidin agarose beads and used in a`pull-down' reaction from HeLa cell extract, followed by immunoblot analysis as described above. PCNA binds to these regions in Rad2 of S pombe (peptide 92) and RAD27 of S cerevisiae (peptide 93), demonstrating evolutionary conservation of the binding motif ( Figure 4a ). The majority of the PCNA present in undepleted HeLa extract was precipitated by these peptides, showing similar PCNA-binding anity to human Fen1. These 20 amino acid peptides share the eight amino acid sequence QGRLDxFF (Figure 4b ), which seems likely to represent a PCNA binding motif. This motif is found in one of the three conserved regions in members of the Fen1 family, the other two being associated with nuclease activity (Carr et al., 1993; Scherly et al., 1993, Harrington and Leiber, 1994b) . The motif of Fen1 required for PCNA interaction appears homologous to the residues critical for PCNA binding within a short peptide (p21PBP) derived from p21 Cip1 . These critical residues in p21PBP were de®ned by systematic alanine substitution , and are found to be identical to or highly conserved (e.g. phenylalanine to tyrosine) with the Fen1 PCNA-binding consensus sequence derived above (Figure 4 ). In view of this similarity of binding sites, we tested the hypothesis that Fen1 and p21
Cip1 might compete for binding to PCNA. Peptide 84 of Fen 1 (Fen1PBP) was immobilised in ELISA wells, Figure 3 Peptide mapping of the PCNA binding site on human Fen1. Twenty-mer overlapping biotinylated peptides of Fen1 covering the 88 amino acids region isolated in the yeast two hybrid screen were immobilised on streptavidin agarose beads and incubated with HeLa cell extract. After precipitation of the beads, associated proteins were separated on 10% SDS ± PAGE, transferred to nitrocellulose and probed using the anti-PCNA monoclonal antibody PC10 (Waseem and Lane, 1990) followed by HRP-anti mouse antibody and visualised using the ECL system. PCNA precipitation by p21PBP was used as positive control, and the amount of PCNA present in undepleted HeLa extract is shown for comparison. Lanes are numbered according to the peptide used, as designated in Materials and methods
Fen1 and p21
Cip1 compete for binding to PCNA E Warbrick et al and recombinant human PCNA was added, together with increasing amounts of a non-biotinylated 9-mer peptide of p21
Cip1 containing the critical amino acids for PCNA interaction, QTSMTDFYH . This short peptide of p21Cip1 clearly competes for PCNA binding to Fen1PBP in vitro ( Figure 5 ). When both p21PBP and Fen1PBP were incubated in solution with PCNA prior to application to a streptavidin-coated plate, it was again observed that PCNA bound preferentially to p21PBP (data not shown). The relative anities of p21PBP and Fen1PBP were then measured using peptide dilution series in a similar ELISA-type reaction. PCNA was found to bind signi®cantly to 1 nmole of Fen1 peptide 84, while the same degree of PCNA binding under identical conditions was obtained using 0.2 nmoles p21PBP (data not shown). These results suggest that p21PBP has an anity for PCNA approximately ®ve times higher than that of Fen1PBP, and may account for the ability of p21PBP to bind preferentially to PCNA in the presence of Fen1PBP. The direct competition between FenPBP and p21PBP for association with PCNA provides a convenient method for assaying small molecules or drugs that bind PCNA and may inhibit its activity in DNA replication.
Cip1 bind to the same region of PCNA
To de®ne the region of PCNA important for Fen1 binding, we created a series of deletion constructs of PCNA fused to GAL4 AS and examined their ability to interact in the two hybrid system with a Fen1 fusion protein. The results (Figure 6 ) show that the Fen1 binding site lies within residues 100 ± 261, and is likely to be located in the region between residues 100 and 150 of PCNA, though it is still possible that residues 150 ± 261 may be involved. This region corresponds to the central loop of PCNA between the two structurally conserved domains of each monomer, and includes the structural motifs bI1, bA2 and aA2 (from the crystal structure of S. cerevisiae PCNA, (Krishna et al., 1994) . The central loop domain of PCNA provides a probable site for intermolecular interaction as it is highly exposed in native PCNA (Krishna et al., 1994) . We show that p21
Cip1 has an identical pattern of binding to these PCNA deletion constructs ( Figure 6 ; , which is in contrast to the pattern of binding by Gadd45 . This data suggests that Fen1 and p21
Cip1 bind to the same region of PCNA. Recently the structure of the C-terminal region of p21
Cip1 complexed with PCNA has been determined (Gulbis et al., 1996) . Their results are entirely consistent with those reported previously , that the central loop of PCNA is required for p21 Cip1 binding, and suggest models for Fen1 binding to PCNA (see Discussion)
A p21 Cip1 -derived peptide disrupts Fen1-PCNA association PCNA and Fen1 have both been implicated in DNA replication, and show a functional interaction. We have extended the analysis of their interaction to show that it occurs during DNA replication in vitro. SV40 DNA was replicated in a large T antigen-dependent manner in HeLa extract (e.g. Stillman and Gluzman, 1985; Li and Kelly, 1984; Wobbe et al., 1985) . During replication, the interaction was analysed by immunoprecipitation with anti-Fen1 antibodies followed by immunoblotting with PC10 against PCNA (Figure 7) . These peptides were used in a precipitation reaction as described in Figure 3 . p21PBP was used as a positive control, and streptavidin-agarose beads alone as the negative control. Undepleted HeLa extract is shown for comparison. (b) The sequences of peptides that bound to PCNA in the precipitation assay were aligned, giving a Fen1 family consensus sequence of QGRLdxFF. This Fen1 consensus was compared with the PCNA binding site on p21 Cip1 (p21PBP, Warbrick et al., 1995) and the homologous region of p21Cip1 from mouse (Huppi et al., 1994) . Boxed residues indicate those residues of p21PBP de®ned by alanine scanning substitution in peptides to be critical for interaction with PCNA: these were found to be highly conserved when compared to the Fen1 PCNA-binding site Figure 5 A short peptide of p21
Cip1 competes with Fen1PBP for binding to PCNA. Biotinylated Fen1PBP (peptide 84 of Figure  4b ) was immobilized on ELISA dishes pre-coated with streptavidin. Bacterial cell lysate overexpressing recombinant human PCNA was mixed with increasing amounts of a nonbiotinylated 9 amino acid peptide QTSMTDFYH derived from p21PBP , then binding of PCNA to the immobilised Fen1PBP was measured using a polyclonal antibody 3009 against PCNA, followed by HRP-anti-rabbit antibody and colorimetric detection at 450 nm (closed circles). An unrelated 20-mer peptide was used as negative control (open circles). The p21
Cip1 peptide at only 1 mg/ml (approximately 1 mM) completely prevented PCNA binding to Fen1PBP
Cip1 compete for binding to PCNA E Warbrick et al A signi®cant amount of PCNA was shown to coimmunoprecipitate with Fen1 ( Figure 7) . Interestingly, the amount of PCNA co-immunoprecipitating with Fen1 was higher when the replication reaction was in log phase (30 min time point). These data suggest that Fen1 may preferentially associate with PCNA during DNA synthesis, possibly through a substrate-mediated interaction.
We have previously demonstrated that p21PBP eciently inhibits SV40 DNA replication in human cell extract . Additionally, we here demonstrate competition between homologous motifs of Fen1 and p21
Cip1 for binding in vitro to the same site on PCNA ( Figure 5 ). We therefore asked whether addition of p21PBP to the replication reaction prevented Fen1-PCNA association. p21PBP (or DMSO solvent control) was added to the SV40 DNA replication reaction, and at 30 min (during log phase replication), samples were immunoprecipitated with protein G-sepharose beads precoated with 3009 anti-PCNA polyclonal antibody, 3220 anti-Fen1 polyclonal antibody, or preimmune serum. Additionally, samples from the same replication reaction were incubated with streptavidin-agarose beads, to pull down the biotinylated p21PBP and any associated proteins. PCNA was found to be present in both the anti-PCNA and the anti-Fen1 immunoprecipitates at signi®cant levels in control samples without added p21PBP (Figure 8 ), while no PCNA was precipitated by either streptavidin agarose beads alone or protein G beads coated with preimmune serum. In contrast, when samples were treated with p21PBP-conjugated streptavidin agarose beads, large amounts of PCNA co-precipitated with the beads, and there was a concomitant loss of PCNA from the Fen1 immunoprecipitates. These experiments demonstrate that addition of p21PBP to replicating HeLa cell extract results in the dissociation of the Fen1-PCNA complex, with PCNA binding preferentially to the p21PBP peptide. This may account for the observed inhibition of DNA replication by the p21PBP peptide . Cip1 binding to PCNA. An entire PCNA monomer is shown schematically, with structural domains designated as described by Krishna et al. (1994) . A series of N terminal and C terminal deletions of PCNA was constructed in frame with the DNA binding domain of Gal4, and expressed in the two hybrid system with Fen1 expressed as a fusion protein with the transcriptional activation domain of Gal4. Reconstitution of a functional transcription factor was scored (ticks) by a colour change from white to blue on X-gal media, and veri®ed by growth in 3AT medium. None of these PCNA constructs alone activated transcription when transformed into Y190 without any other plasmid. In a parallel series of experiments, interaction of p21 Cip1 to the PCNA constructs was assayed. In contrast to the binding pattern shown by Gadd45 Figure 8 p21PBP disrupts Fen1-PCNA complex assembly and blocks DNA replication SV40 DNA was replicated in vitro for 30 min in the presence (p21PBP) or absence (DMSO) of a biotinylated 20mer peptide from p21 Cip1 that binds PCNA . Samples were immunoprecipitated using anti-PCNA 3009, anti-Fen1 3220, preimmune serum (`PIS') from the animal in which the anti-Fen1 antibody was subsequently raised, or streptavidin-coated agarose beads (`Str.'). Undepleted replication mix (`HeLa') was also loaded to show the amount of protein prior to depletion. Immunoblots were probed with monoclonal antibody PC10 against PCNA. Note the presence of PCNA in Fen1 precipitates in the control (`DMSO') but not in the presence of p21PBP. In the absence of p21PBP, PCNA does not associate with streptavidin beads, whereas PCNA bound by p21PBP is precipitated on the streptavidin beads
Cip1 compete for binding to PCNA E Warbrick et al Discussion PCNA is fundamental to nuclear DNA replication, acting as a sliding clamp that tethers the leading strand DNA polymerase d to its template, enhancing the enzyme's processivity (Prelich et al., 1987; Bravo et al., 1987; Krishna et al., 1994) . In addition, PCNA is required for nucleotide excision repair (Shivji et al., 1992; Nichols and Sancar, 1992) and is involved in one pathway of base excision repair (Matsumoto et al., 1994) . PCNA may be recruited to these dierent roles in replication and repair by interaction with proteins speci®c to each process. Examination of PCNA's partners is therefore a critical goal in the understanding of both DNA repair and DNA replication.
We have identi®ed here an interaction between PCNA and the¯ap endonuclease Fen1 (Harrington and Lieber, 1994a,b) , also known as DNase IV (Robins et al., 1994) ; rad2hs, (Murray et al., 1994) , and MF1 (Waga et al., 1994a) , using a two hybrid screen. We have veri®ed that the interaction between full length Fen1 and PCNA proteins is direct by FarWestern analysis. Similar results have recently been reported by Li et al. (1995) with S cerevisiae proteins, and Wu et al. (1996) with human proteins, who have shown that Fen1 and PCNA interact, and that PCNA binding has functional implications for the nuclease activity of Fen1.
In the two hybrid system, we found that human Fen1 could interact with PCNA from D melanogaster and S pombe, demonstrating a high degree of evolutionary conservation. Murray et al. (personal communication) have shown that the S pombe Fen1 homologue Rad2 interacts with PCNA, using both two hybrid analysis and immunoprecipitation of tagged proteins from S pombe cells, which provides further support for the conservation of this interaction in widely divergent species.
Analysis of the various Fen1-encoding plasmids identi®ed in the two hybrid screen allowed us to localise the PCNA binding site. The largest fragment identi®ed encoded full length Fen1, while the smallest expressed only the C-terminal 88 amino acids. To further de®ne the PCNA binding site, we analysed the binding of PCNA to a set of arti®cially synthesised peptides derived from the Fen1 amino acid sequence. Three overlapping peptides which bind to PCNA allowed us to de®ne a 10 amino acid region as capable of binding PCNA. Examination of the sequences of human, S cerevisiae and S pombe homologues of Fen1 revealed that this region is highly conserved, with an 8 amino acid domain with consensus QGRLDxFF (where`x' is not conserved). We have shown that peptides derived from this conserved region in the yeast Fen1 homologues were capable of binding human PCNA, which indicates that this conserved site does indeed represent a conserved PCNA binding domain.
In our two hybrid screen, two proteins were identi®ed as interacting with human PCNA: p21 Cip1 , and Fen1 (this work). We demonstrate that Fen1 and p21
Cip1 show an identical pattern of binding to a series of amino terminal and carboxyl terminal deletions of PCNA in the two hybrid system. This is in contrast to the PCNA binding pattern shown by Gadd45, a DNA damage inducible protein which interacts with both PCNA and p21 Cip1 (Smith et al., 1994; Hall et al., 1995; Kearsey et al., 1995) , and suggests that p21
Cip1 and Fen1 bind to the same region of PCNA. This region includes residues exposed in a loop between the two domains of each PCNA monomer, which is a likely site for intermolecular interactions, as it is highly exposed in native PCNA (Krishna et al., 1994) .
Recently the structure of a C-terminal 22 amino acid region of p21
Cip1 complexed with human PCNA has been determined (Gulbis et al., 1996) . A p21
Cip1
-derived peptide (GRKRRQTSMTDFYHSKRRLIFS) which is very similar to the 20 amino acid peptide p21PBP, makes contacts with three distinct regions of the PCNA surface. The N-terminal region (GRKRR) interacts with the C-terminus of PCNA, the Cterminus (HSKRRLIFS) forms an anti-parallel bsheet with the central loop, and the central residues of the peptide (QTSMTDFY) are anchored in a hydrophobic cleft between the central loop, two other loops in the structure, and the C-terminus of the PCNA molecule. The residues of p21
Cip1 critical for binding to PCNA have been de®ned by sequential alanine substitution . These results have proved to be entirely consistent with the structural data, which supports the use of peptides in the analysis of protein-protein interactions. Comparison of these critical p21
Cip1 residues with the PCNA binding consensus within Fen1 and its homologues shows that these speci®c residues are either identical or highly conserved. Interestingly, it is the residues central to the p21 Cip1 derived peptide which interact with the hydrophobic pocket within the PCNA structure that are particularly conserved between p21
Cip1 and Fen1. This motif therefore de®nes a novel PCNA binding consensus sequence, and is highly suggestive that Fen1 and p21
Cip1 share a common PCNA binding mechanism. Since Fen1 and p21
Cip1 share amino acids essential for PCNA binding, and appear to bind to the same site on PCNA, it is highly likely that the two proteins will compete for PCNA binding.
Addition of the PCNA binding peptide derived from p21 Cip1 , p21PBP, results in the inhibition of SV40 DNA synthesis in vitro . Here we show that p21PBP competes with endogenous Fen1 protein for binding to PCNA, an eect which is concomitant with the inhibition of DNA replication. Addition of this peptide is therefore results in the complete dissociation of the Fen1-PCNA complex, with PCNA binding instead to the p21 Cip1 -derived peptide. Several models have been proposed to explain the inhibition of DNA synthesis by p21
. Neither the loading of PCNA onto DNA by the RF-C complex, nor the ability of PCNA to move along DNA is aected by p21
Cip1 . Binding of the p21
Cip1 peptide does not interfere with PCNA structure, or its ability to trimerise, suggesting that the eect of p21
Cip1 in inhibiting PCNA function in DNA replication is to prevent interaction with other proteins (Gulbis et al., 1996) . Recently, Savio et al. (1996) have shown that nuclear binding of PCNA at DNA repair sites occurs with a kinetics faster than that exhibited by p21
, although an insoluble complex containing both proteins is detected.
Our data suggests that the action of p21 Cip1 in inhibiting DNA synthesis is to bind to PCNA and
Fen1 and p21
Cip1 compete for binding to PCNA E Warbrick et al prevent the Fen1-PCNA interaction. The reason why dissociation of the Fen1-PCNA interaction should result in the inhibition of DNA replication is not clear, but several possibilities exist. Fen1 is essential for the lagging strand replication reaction, so loss of this activity would prevent the complete processing of Okazaki fragments. It is possible that this could be sensed by the replication machinery, and halt the replication complex. It is also possible that disruption of the Fen1-PCNA interaction results in a destabilisation of the whole replication complex. However, p21
Cip1 does not appear to inhibit the role of PCNA in nucleotide excision repair, so possibly p21 Cip1 bound PCNA is still competent for DNA repair, in which case it must still be able to interact with DNA polymerases. These possibilities remain to be explored.
Such alterations in PCNA function might provide a direct link between the cessation of DNA replication following DNA damage, and the onset of DNA repair. Consistent with this hypothesis, p21
Cip1 is transcriptionally induced by the human tumour suppressor protein p53 (El-Deiry et al., 1993) which is itself induced in response to genomic damage (reviewed by Cox and Lane, 1995) . Coupled with higher levels of p21 Cip1 following genomic damage, the higher anity of p21
Cip1 than Fen1 for PCNA might well result in total replacement of Fen1 on PCNA by p21 Cip1 under conditions of genotoxic stress. However, it is equally possible from our results that PCNA can be shifted from replication to repair according to the ratio of p21
Cip1 and Fen1 bound to the same PCNA trimer. These speculative hypotheses can be tested when further stoichiometric information concerning the binding of Fen1 and p21
Cip1
to PCNA becomes available.
In summary, we have de®ned a minimal PCNA binding motif, demonstrated a direct interaction between Fen1 and PCNA in vitro, and veri®ed that human PCNA can interact with human Fen1 in mammalian cell extracts. We show that Fen1-PCNA complex assembly is prevented from forming in the presence of the PCNA-binding region of p21
. These results showing a competition for binding to PCNA between p21
Cip1 and Fen1, may provide a mechanistic link co-ordinating the inhibition of DNA replication with the onset of repair following DNA damage.
Materials and methods
Cloning and plasmid expression constructs
Manipulations of E coli and DNA were by standard methods (Sambrook et al., 1989) . All plasmid constructs containing fragments produced by PCR were initially subcloned into pBC-SK (Stratagene) and sequenced using oligonucleotide primers on one strand to check for PCR errors before a second subcloning step into the required expression vector. Double stranded plasmid DNA was sequenced using the Sequenase TM protocol (USB), and sequence analysis used the UWGCG package at the Daresbury Seqnet facility. The plasmids encoding full length PCNA from Drosophila melanogaster (pAS-PCNADm) and Schizosaccharomyces pombe (pAS-PCNA-Sp), and full length or fragments of human PCNA (pAS-PCNA-Hs) have been described previously Hall et al., 1995) .
Yeast two hybrid methods
Growth and maintenance of S cerevisiae was according to Rose et al., (1990) . Transformation was carried out by the method of Gietz et al. (1992) . All growth was carried out at 308C. The S cerevisiae strain Y190 (MATa leu2-3, 112 ura3-52 trp1-901 his3-D200 ade2-101 gal4D gal80D cyh R URA3 : : GAL1-lacZ LYS2 : : GAL1-HIS3) was used for all two hybrid analysis. This strain expresses the reporter genes lacZ (E coli) and HIS3 (S cerevisiae) under the control of the GAL1 promoter. The HIS3 reporter construct described here gives residual HIS3 expression though not sucient to render cells resistant to 3-aminotriazole, a chemical inhibitor of HIS3 (IPG dehydratase) at 50 mM. In order to test for HIS3 expression from the GAL1 promoter, cells were streaked out on SD plates containing 50 mM 3-aminotriazole, incubated for 1 week and plates examined for the formation of single colonies. Where growth occurred, lacZ expression was assayed by a ®lter lift for b-galactosidase (Breeden and Nasmyth, 1985) . Only transformants which expressed both reporter genes were counted as true positives. Plasmid DNA was recovered from S cerevisiae essentially by the method of Homan and Winston (1987) and further puri®ed using GeneClean TM (Stratagene). The E coli strain JA226 was used; ampicillin resistant colonies were tested for leucine prototrophy to determine whether they contained a pACT or pAS derived plasmid, as the LEU2 sequences in pACT complement the leuB6 mutation in JA226. Two hybrid screening was otherwise carried out as described previously .
Production of anti-Fen1 antibody 3220
The Fen1 full length open reading frame was cloned into pET23d (Novagen) as an NcoI ± BglII fragment from one of the Fen1 clones isolated in the two hybrid screen. Competent E coli BL21(DE3) cells were transformed with this plasmid and induced to express Fen1 by IPTG treatment. Insoluble inclusion bodies were isolated from transformed cell lysates, and the expressed Fen1 protein puri®ed by preparative SDS ± PAGE. A rabbit was immunised by subcutaneous injection of the puri®ed protein in Freund's complete adjuvant, followed by monthly boosts with the protein in Freund's incomplete adjuvant.
Immunoprecipitation
Polyclonal antibodies 3009 against PCNA, 3220 against Fen1 or preimmune serum from the rabbit in which the Fen1 antibody was subsequently raised were coupled to protein G sepharose beads (Pharmacia) by incubating 5 ml serum with 10 ml washed and packed beads in 200 ml PBS for 1 h at room temperature with rotation. Beads were washed extensively in PBS then incubated on ice with 20 mg (total protein) cell lysate or replication reaction for 90 min. After recovery by centrifugation at 15 800g for 15 s, beads were again washed extensively in PBS then boiled in SDS loading dyes with 0.2 M DTT prior to separation on 10% SDS ± PAGE followed by transfer to nitrocellulose (Schleicher and Schuell).
Peptide precipitations and Western blotting
The following 20 amino acid peptides with 16 amino acid overlaps were synthesized (Chiron Mimotopes, Australia) across the C terminal 88 amino acids of Fen1 identi®ed in the two hybrid screen as the PCNA binding site on Fen1: The peptide derived for S pombe Rad2 was: ASK-TIPQGRLDSFFKPVPSS, and that from S cerevisiae RAD27 was: GLKSGIQGRLDGFFQVVPTK. These peptides were linked via residues SGSG at the amino terminus to biotin. 2.7 mg of each peptide was incubated with 10 ml streptavidin agarose beads (Sigma) in phosphate buered saline (PBS) for 1 h at room temperature (r.t.) then beads were washed extensively in PBS and recovered each time by centrifugation at 11 600 g. HeLa cell lysate was added the washed beads to a ®nal concentration of 1 mg/ml and incubated with the beads on ice for 1 h. Beads were extensively washed in PBS with 220 mM NaCl, then bound proteins removed by boiling for 8 min in SDS loading buer with 0.2 M DTT. Proteins were separated on 10% SDS ± PAGE then electrophoretically transferred to nitrocellulose. Blots were blocked then incubated for 1 h r.t. with PC10 hybridoma supernatant (Waseem and Lane, 1990 ) diluted 1 : 5 in DMEM with 10% FCS. After washing, blots were incubated with secondary HRPconjugated rabbit/swine anti-mouse IgG serum at 1 : 1000 in 2% non-fat milk-PBS-0.2% Tween for 1 h r.t. Bound antibody was visualized using the ECL system according to the manufacturer's instructions (Amersham plc).
Far-Western blotting
Cells expressing recombinant Fen1 (as described above), were harvested and lysed by sonication. Protein concentration of the lysate was determined by the Bradford assay, and approx. 10 mg total protein was denatured in loading dyes (with 2% SDS and 0.2M DTT) then loaded across a 10% SDS gel using a preparative comb (BioRad MiniProtean II). After electrophoresis and electrophoretic transfer to nitrocellulose, the blot was cut into 3 mm strips, blocked in 5% non-fat milk-PBS-0.2% Tween, and then incubated for 2 h at room temperature with either 6mg HeLa cell extract, 0.3 mg E coli lysate expressing recombinant human PCNA or 0.3 mg recombinant Fen1 cell lysate. After extensive washing, the strips were incubated with antibodies 3009 against PCNA or 3220 against Fen1 (1 : 1000) for 1 h, followed by secondary HRP conjugated anti-rabbit antibody. Antibodies and other proteins were diluted in DMEM with 10% FCS. The signal was visualised using the ECL system (Amersham).
Competitive ELISA ELISA plates were coated overnight at 378C with 100 ng of streptavidin per well. Plates were blocked with 5% non-fat milk powder in PBS, washed extensively with PBS containing 0.2% Tween 20 (PBS-T) then 100 ml Fen1 peptide 84 (Fen1PBP) at 10 mg/ml was added to each well. Following 1 h incubation at r.t. in a humid chamber, wells were washed extensively. Approximately 6 mg total protein containing overexpressed recombinant human PCNA was mixed with varying concentrations of a nine amino acid peptide derived from p21PBP , of the sequence QTSMTDFYH (puri®ed by HPLC and veri®ed by mass spectrometry) and applied to the wells for 1 h at r.t. After extensive washing, anti-PCNA polyclonal antibody 3009 was added at 1 : 1000, followed by HRP-conjugated anti-rabbit IgG serum at 1 : 1000 and bound antibody was visualised by the TMB colorimetric procedure (Harlow and Lane, 1988) . Plates were read at 450 nm using a Dynatech 5000 plate reader.
DNA replication assays
SV40 DNA replication reactions were carried out essentially as described by Stillman and Gluzman (1985) , except that ®nal reaction volumes were 10 ml. Brie¯y, 40 mg HeLa S100 cell extract was mixed on ice with 60 ng pSVDE1 plasmid containing the SV40 origin of replication in pBR322, 250 ng puri®ed SV40 large T antigen, 200 mM of each of the ribonucleotides UTP, GTP and CTP, 100 mM of each of the deoxyribonucleotides dATP, dCTP and dGTP and 20 mM [ 3 H]dTTP (Amersham). The replication reaction was supplemented with 4 mM ATP, 33.5 mg/ml creatine phosphokinase and 20 mM phosphocreatine pH 7.7 as energy regenerating system, and samples were made up to a ®nal volume of 10 ml with distilled H 2 O. Where appropriate, 500 ng p21PBP peptide, or the equivalent volume of the peptide solvent DMSO, was added. Reactions were then incubated at 378C. Extent of replication was assayed by incubating samples on ice for 10 min with 50 ml 0.15 M sodium pyrophosphate, 50 ml salmon sperm carrier DNA (1 mg/ml) and 900 ml 10% trichloroacetic acid (TCA), then passing samples through Whatman GF-C ®lters (presoaked in ice cold 1% TCA) which were washed successively with ice cold 1% TCA then 100% ethanol. Filters were air dried then counted in Econo¯uor scintillant (Dupont) using a Beckman LS1801 scintillation counter.
